MEDSTONE STS LITHOTRIPTER

Lithotripter, Shockwave (for Treating Gallbladder Stones)

FDA Premarket Approval P970042 S001

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for several changes to the post-approval study protocol. Specifically, these changes are 1) changes to inclusion criteria 3 and 5 2) changes to exclusion criteria 7, 8, 9, 10, 11, 13, 15, and 16 3) elimination of the ultrasound evaluation immediately post-lithotripsy, 4) elimination of the oral cholecystogram at the six-month visit, and 5) addition of statements to clarify guidelines for scheduling follow-up visits and to list protocol requirements by study visit.

DeviceMEDSTONE STS LITHOTRIPTER
Classification NameLithotripter, Shockwave (for Treating Gallbladder Stones)
Generic NameLithotripter, Shockwave (for Treating Gallbladder Stones)
ApplicantMEDSTONE INTL., INC.
Date Received2000-12-18
Decision Date2001-02-05
PMAP970042
SupplementS001
Product CodeNCV
Advisory CommitteeGastroenterology/Urology
Supplement TypeNormal 180 Day Track
Supplement ReasonPostapproval Study Protocol - Ode/oir
Expedited ReviewNo
Combination Product Yes
Applicant Address MEDSTONE INTL., INC. 100 Columbia, Suite 100 aliso Viejo, CA 92656-4114

Supplemental Filings

Supplement NumberDateSupplement Type
P970042Original Filing
S004 2002-08-02 Normal 180 Day Track
S003 2002-07-03 Normal 180 Day Track
S002 2002-02-21 Normal 180 Day Track
S001 2000-12-18 Normal 180 Day Track

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.